Neoplasia/BPH

	Mature Testicular Teratoma Mimicking Hydrocele in a 3-Year-Old Boy: Case Report and Literature Review. J Investig Med High Impact Case Rep Thabaineh RW, Mujahed RH, Almashaiekh TM, Aldarabee I, Wridat RN, Smerat MI, Alsalah QA. PMID: 41431937 [PubMed - indexed for MEDLINE]
	Combining Prostate-Specific Antigen Density With PI-RADS to Improve the Detection of Clinically Significant Prostate Cancer at MRI/TRUS Fusion-Targeted Re-Biopsy. Prostate Ono Y, Kohada Y, Tasaka S, Miyamoto S, Hayashi T, Honda Y, Kitamura N, Tasaka R, Kobatake K, Sekino Y, Kitano H, Goto K, Goriki A, Hieda K, Kato M, Takeshima Y, Hinata N. PMID: 41431453 [PubMed - as supplied by publisher]
	Association between grain intake and prostate-specific antigen: A cross-sectional study from US men. Medicine (Baltimore) Xie H, Wang S, Liang Y, Zhao X, Liu H, Jiang B, Liu D, Xu Y, Zhang H. PMID: 41431103 [PubMed - indexed for MEDLINE]
	Evaluating the relationship between educational attainment, obesity-related indicators, and prostate diseases: A univariable and multivariable Mendelian randomization study. Medicine (Baltimore) Ji WT, Wang YK, Jin XF, Wang SQ, Wang Y. PMID: 41431082 [PubMed - indexed for MEDLINE]
	Insights into the impact of neuropsychiatric disorders on prostate diseases: A 2-sample Mendelian randomization study. Medicine (Baltimore) Xie H, Geng W. PMID: 41430987 [PubMed - indexed for MEDLINE]
	Docetaxel versus androgen receptor pathway inhibitors as first-line therapy for metastatic castration-resistant prostate cancer after doublet therapy: a multicenter retrospective study from Saudi Arabia. BMC Urol Bazarbashi S, Abdelmotal AS, Arabi T, Fallatah W, Alzannan N, Elhassan T, Aseafan M, Mahroos M, Aljishi M, Busbaih A, Aldandan R, Rauf MS, Almugbel FA, Azam F, Almansour M. PMID: 41430171 [PubMed - as supplied by publisher]
	The impact of digital interactive interventions on survivorship outcomes in prostate cancer: a systematic narrative review. BMC Cancer Maleki M, Mardani A, Sadeghi N, Allahmoradi Z, Molaie N, Sajadi MA, Vaismoradi M. PMID: 41430143 [PubMed - as supplied by publisher]
	Urethra contours on MRI: Multidisciplinary consensus educational atlas and reference standard for artificial intelligence benchmarking. Radiother Oncol Song Y, Nguyen L, Dornisch AM, Baxter MT, Barrett T, Dale AM, Dess RT, Harisinghani M, Kamran SC, Liss MA, Margolis DJA, Weinberg EP, Woolen SA, Seibert TM. PMID: 41429726 [PubMed - indexed for MEDLINE]
	Re: Himanshu Nagar, Marshall A. Diven, Brady Rippon, et al. A Randomized Controlled Phase 2 Trial Comparing Salvage Radiotherapy for Prostate Cancer Delivered in 4 Versus 2 Weeks (SHORTER): Acute Genitourinary and Gastrointestinal Patient-reported Outcomes at a Single Institution. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2025.05.014. Eur Urol Oncol Montorsi F, Zaurito P, Gandaglia G, Briganti A. PMID: 41429700 [PubMed - in process]
	Impact of Implementation of Risk Calculators for the Selection of Extended Pelvic Lymph Node Dissection Candidates: 20-year Experience from a Tertiary Referral Centre. Eur Urol Oncol Barletta F, Scuderi S, Scilipoti P, Longoni M, Quarta L, Pellegrino A, Cannoletta D, Leni R, Zaurito P, Santangelo A, Gettman A, Viti A, Cosenza A, Brancaccio M, Stabile A, Montorsi F, Gandaglia G, Briganti A. PMID: 41429699 [PubMed - indexed for MEDLINE]
	Prostate cancer radiation therapy shape variation analysis. Phys Eng Sci Med Leung SN, Dowling JA, Greer P, Chandra SS. PMID: 41428189 [PubMed - as supplied by publisher]
	Cuproptosis-related gene DLD expression correlates with the prognosis and tumor immune microenvironment in clear cell renal cell carcinoma. Discov Oncol Qian C, He H, You G. PMID: 41428162 [PubMed - as supplied by publisher]
	Smooth Muscle Disruptive Feature Defines Molecular Subtyping, Risk Stratification, and Metastatic Potential in Prostate Cancer. Ann Surg Oncol Luo Y, Jiang Z, Liu Z, Deng X, Wang J, Su S. PMID: 41428021 [PubMed - as supplied by publisher]
	Design and Synthesis of Novel Chalcone Derivatives Targeting Bladder and Liver Cancer: Cytotoxicity Evaluation and Preliminary Mechanistic Studies. ACS Omega Hermenegildo AM, Nakao IA, Vaz LBA, Coutinho GG, Toledo JLM, Almeida TC, Roquete Amparo T, Anunciação KF, da Silva GN, Brandão GC, Braga SFP, de Souza TB. PMID: 41427178 [PubMed]
	Sarcomatoid and Unclassified Renal Neoplasms: Histology, Immunology, and Genomics. Cureus Qasim H, Hayajneh A, Abuuqteish H, Khattab K, Leoni MLG, Varrassi G. PMID: 41426798 [PubMed]
	Neoadjuvant Therapy to Enable Partial Nephrectomy in Patients With High-Complexity or Locally Advanced Non-metastatic Renal Cell Carcinoma: A Systematic Review and Meta-Analysis. Cureus Abusal F, Alawadi A, Alsharief M, Zeid A, Obeidat S, Wreikat M, Serag H. PMID: 41426783 [PubMed]
	Development and validation of a nomogram for predicting clinically significant prostate cancer using serologic indices, multiparametric magnetic resonance imaging, and sound touch elastography parameters: a retrospective study. Front Oncol Shu K, Chen Q, Chen J, Xu Q, Jin Y. PMID: 41426319 [PubMed]
	Long non-coding RNAs define favourable biology in high-risk non-muscle-invasive bladder cancer. BJUI Compass Weng R, Phung TAT, Bell R, Dyrskjøt L, Gibb EA. PMID: 41425537 [PubMed]
	Urinary biomarkers in multicentric studies: Shaping the future of bladder cancer diagnosis and follow-up. BJUI Compass Martel A, Raue L, Avogbe PH, Raisch J, Jeldres C, Ecke T, Vian E, Hosen MI, Rabien A, Le Calvez-Kelm F, Boisvert FM. PMID: 41425536 [PubMed]
	Evolving frontiers in bladder cancer immunotherapy: integrating BCG, immune checkpoints, viral vectors, nanotechnology, and CAR-based therapies. Front Cell Dev Biol Di Spirito A, Zuccolotto G, Tosi A, Balkhi S, Rosato A, Baci D, Mortara L. PMID: 41425090 [PubMed]

Articles 1 - 20 / 184160

Page 1 of 9208



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy